Oneness Biotech Co., Ltd.

BDL:ONEA Stock Report

Market Cap: US$1.3b

Oneness Biotech Valuation

Is ONEA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ONEA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate ONEA's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate ONEA's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for ONEA?

Key metric: As ONEA barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for ONEA. This is calculated by dividing ONEA's market cap by their current book value.
What is ONEA's PB Ratio?
PB Ratio3.2x
BookNT$13.08b
Market CapNT$42.49b

Price to Book Ratio vs Peers

How does ONEA's PB Ratio compare to its peers?

The above table shows the PB ratio for ONEA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PBEstimated GrowthMarket Cap
Peer Average7.2x
002755 Beijing Aosaikang Pharmaceutical
4.2x21.7%CN¥12.6b
002693 Hainan Shuangcheng Pharmaceuticals
20.7xn/aCN¥9.0b
4506 Sumitomo Pharma
2x88.7%JP¥230.0b
688553 Sichuan Huiyu Pharmaceutical
1.8xn/aCN¥7.1b
ONEA Oneness Biotech
3.2x36.8%US$42.5b

Price-To-Book vs Peers: ONEA is good value based on its Price-To-Book Ratio (3.2x) compared to the peer average (7.2x).


Price to Book Ratio vs Industry

How does ONEA's PB Ratio compare vs other companies in the European Pharmaceuticals Industry?

10 CompaniesPrice / BookEstimated GrowthMarket Cap
ONEA 3.2xIndustry Avg. 2.2xNo. of Companies15PB01.63.24.86.48+
10 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Book vs Industry: ONEA is expensive based on its Price-To-Book Ratio (3.2x) compared to the European Pharmaceuticals industry average (2.2x).


Price to Book Ratio vs Fair Ratio

What is ONEA's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ONEA PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio3.2x
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate ONEA's Price-To-Book Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies